- Home
- HFBL vs RLYB Comparison
HFBL vs RLYB Comparison
Compare HFBL & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HFBL
- RLYB
- Stock Information
- Founded
- HFBL 1924
- RLYB 2018
- Country
- HFBL United States
- RLYB United States
- Employees
- HFBL N/A
- RLYB N/A
- Industry
- HFBL Savings Institutions
- RLYB Biotechnology: Pharmaceutical Preparations
- Sector
- HFBL Finance
- RLYB Health Care
- Exchange
- HFBL Nasdaq
- RLYB Nasdaq
- Market Cap
- HFBL 39.4M
- RLYB 42.3M
- IPO Year
- HFBL N/A
- RLYB 2021
- Fundamental
- Price
- HFBL $12.29
- RLYB $0.99
- Analyst Decision
- HFBL
- RLYB Buy
- Analyst Count
- HFBL 0
- RLYB 6
- Target Price
- HFBL N/A
- RLYB $8.10
- AVG Volume (30 Days)
- HFBL 2.1K
- RLYB 70.0K
- Earning Date
- HFBL 10-29-2024
- RLYB 11-07-2024
- Dividend Yield
- HFBL 4.24%
- RLYB N/A
- EPS Growth
- HFBL N/A
- RLYB N/A
- EPS
- HFBL 1.09
- RLYB N/A
- Revenue
- HFBL $19,727,000.00
- RLYB $598,000.00
- Revenue This Year
- HFBL N/A
- RLYB N/A
- Revenue Next Year
- HFBL N/A
- RLYB N/A
- P/E Ratio
- HFBL $11.30
- RLYB N/A
- Revenue Growth
- HFBL N/A
- RLYB N/A
- 52 Week Low
- HFBL $10.60
- RLYB $0.95
- 52 Week High
- HFBL $15.81
- RLYB $3.46
- Technical
- Relative Strength Index (RSI)
- HFBL 46.34
- RLYB 43.03
- Support Level
- HFBL $12.14
- RLYB $0.96
- Resistance Level
- HFBL $12.40
- RLYB $1.15
- Average True Range (ATR)
- HFBL 0.19
- RLYB 0.06
- MACD
- HFBL -0.01
- RLYB -0.00
- Stochastic Oscillator
- HFBL 31.58
- RLYB 19.30
About HFBL Home Federal Bancorp Inc. of Louisiana
Home Federal Bancorp Inc of louisiana operates as a bank holding company. It is a federally chartered stock savings bank, which provides financial services to individuals, corporate entities, and other organizations. Its core activities consist of attracting deposits from the general public and using those funds to originate loans to the residential, commercial and multi-family segments. The company also invests securities held-to-maturity and securities available for sale.
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.